These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 125227)

  • 41. Two further cases of mutation R1947X in the NF1 gene: screening for a relatively common recurrent mutation.
    Lázaro C; Kruyer H; Gaona A; Estivill X
    Hum Genet; 1995 Sep; 96(3):361-3. PubMed ID: 7649559
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Mutagenic effect of advanced paternal age in neurocardiofaciocutaneous syndrome].
    Seemanová E; Zenker M
    Cas Lek Cesk; 2014; 153(5):242-5. PubMed ID: 25370770
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Possible maternal effect on severity of neurofibromatosis.
    Miller M; Hall JG
    Lancet; 1978 Nov; 2(8099):1071-3. PubMed ID: 82088
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Molecular genetic diagnosis of neurofibromatosis type I].
    Polgár N; Komlósi K; Hadzsiev K; Illés T; Melegh B
    Orv Hetil; 2011 Mar; 152(11):415-9. PubMed ID: 21362601
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neurofibromatosis type I (NFI) in Israeli families: linkage analysis as a diagnostic tool.
    Elyakim S; Lerer I; Zlotogora J; Sagi M; Gelman-Kohan Z; Merin S; Abeliovich D
    Am J Med Genet; 1994 Dec; 53(4):325-34. PubMed ID: 7864041
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Molecular diagnosis as a strategy for differential diagnosis and at early ages of neurofibromatosis type 1 (NF1)].
    Gómez M; Batista O
    Rev Med Chil; 2015 Oct; 143(10):1320-30. PubMed ID: 26633276
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tumor LOH analysis provides reliable linkage information for prenatal genetic testing of sporadic NF1 patients.
    Serra E; Pros E; García C; López E; Gili ML; Gómez C; Ravella A; Capellá G; Blanco I; Lázaro C
    Genes Chromosomes Cancer; 2007 Sep; 46(9):820-7. PubMed ID: 17563086
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular studies in 20 submicroscopic neurofibromatosis type 1 gene deletions.
    Lopez Correa C; Brems H; Lázaro C; Estivill X; Clementi M; Mason S; Rutkowski JL; Marynen P; Legius E
    Hum Mutat; 1999; 14(5):387-93. PubMed ID: 10533064
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Spinal neurofibromatosis in a family with classical neurofibromatosis type 1 and a novel NF1 gene mutation.
    Nicita F; Torrente I; Spalice A; Bottillo I; Papetti L; Pinna V; Ursitti F; Ruggieri M
    J Clin Neurosci; 2014 Feb; 21(2):328-30. PubMed ID: 23954459
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1.
    Ars E; Serra E; García J; Kruyer H; Gaona A; Lázaro C; Estivill X
    Hum Mol Genet; 2000 Jan; 9(2):237-47. PubMed ID: 10607834
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Gastrointestinal stromal tumors in neurofibromatosis type 1].
    Bajor J
    Orv Hetil; 2009 Jan; 150(4):149-53. PubMed ID: 19144598
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Example of somatic mosaicism in a series of de novo neurofibromatosis type 1 cases due to a maternally derived deletion.
    Ainsworth PJ; Chakraborty PK; Weksberg R
    Hum Mutat; 1997; 9(5):452-7. PubMed ID: 9143926
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical and molecular characterization of 112 single-center patients with Neurofibromatosis type 1.
    Corsello G; Antona V; Serra G; Zara F; Giambrone C; Lagalla L; Piccione M; Piro E
    Ital J Pediatr; 2018 Apr; 44(1):45. PubMed ID: 29618358
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of segregation and expression of an identified mutation at the neurofibromatosis type 1 locus.
    Stark M; Assum G; Kaufmann D; Kehrer H; Krone W
    Hum Genet; 1992 Dec; 90(4):356-9. PubMed ID: 1483690
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neurofibromatosis. A clinical and genetic study of 96 cases in Gothenburg, Sweden.
    Samuelsson B; Axelsson R
    Acta Derm Venereol Suppl (Stockh); 1981; 95():67-71. PubMed ID: 6807042
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Neurofibromatosis: the most frequent hereditary tumor predisposition syndrome].
    Wimmer K
    Wien Med Wochenschr; 2005 Jun; 155(11-12):273-80. PubMed ID: 16035388
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Genetic counseling in neurofibromatosis. Apropos of a study of 53 families].
    Toutain A; Kaplan J; Briard ML; Frézal J
    J Genet Hum; 1988 Jun; 36(3):163-71. PubMed ID: 3137311
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Anxiety disorders in type 1 neurofibromatosis: A case report].
    Fekih-Romdhane F; Othman S; Sahnoun C; Helayem S; Abbes Z; Bouden A
    Arch Pediatr; 2015 Sep; 22(9):956-60. PubMed ID: 26228808
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genetic and clinical considerations in six cases with neurofibromatosis type 1.
    Buteică E; Stoicescu I; Burada F; Stănoiu B
    Rom J Morphol Embryol; 2007; 48(3):243-8. PubMed ID: 17914490
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neurofibromatosis type I: mutation spectrum of NF1 in spanish patients.
    Palma Milla C; Lezana Rosales JM; López Montiel J; Andrés Garrido LD; Sánchez Linares C; Carmona Tamajón S; Torres Fernández C; Sánchez González P; Franco Freire S; Benito López C; López Siles J
    Ann Hum Genet; 2018 Nov; 82(6):425-436. PubMed ID: 30014477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.